Tirzepatide Explored for Atrial Fibrillation Management in Obese Patients
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Abstract
TIRO-AF: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
NCT ID: NCT06802081
Status: RECRUITING
Sponsor: The Cleveland Clinic
Start: 2025-04-08 | Completion: 2027-06-01
Conditions: Atrial Fibrillation, Obesity…
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
